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INTRODUCTION 
Paracetamol (PA, acetaminophen) is a popular analgesic. 
Currently, more than 90 products containing PA are 
available over the counter in the UK and are available in 
different dosage forms. The poor compression behaviour of 
PA powders is due to reduced plastic deformation during 
compression, resulting in the formation of soft tablets with 
a high capping tendency (1). Therefore, the aim of this 
work was to produce PA monoclinic crystals with improved 
compaction properties and dissolution rates using generally 
recognized as safe (GRAS) additives, i.e., polyvinyl alcohol 
(PVA), Avicel PH 102, Brij 58, methylcellulose (MC) and 
polyethylene glycols (PEG 1500, PEG 6000 and PEG 
8000). The effect of the concentration of additives on the 
physicomechanical properties of crystallized paracetamol 
(Cry–PA) was also investigated. 
METHODS 
PA was dissolved in ethanol (40 °C, 30%, w/v). Twenty mL 
of this solution was then separately added to 50 mL of 
distilled water containing various additives (Avicel, Brij 58, 
MC, PEG or PVA) at different concentrations, i.e., 0.1%, 
0.5% and 1% (w/w) for Brij 58, MC, PEG and PVA, and 
2% (w/w) for Avicel. The precipitated crystals were 
recovered by vacuum filtration, dried (at 60 °C for 12 h) 
and stored in glass vials until required. PAs were 
characterized in terms of size (laser diffraction), 
morphology (scanning electron microscopy, SEM), solid-
state (differential scanning calorimetry (DSC) and fourier 
transform infrared spectroscopy (FT-IR)), true density 
(Ultrapycnometer 1,000) and flowability (Carr’s index, CI). 
PAs were sieved to collect 90–125 µm particles and 
compressed using a single punch tableting machine 
(Enerpac MTCM–I, Globe Pharma, USA) fitted with 6 mm 
diameter flat–faced punches at 49, 98 and 147 MPa. Tablet 
crushing strength was determined (Dr Schleuniger 
Pharmatron, 8M, Switzerland). The dissolution profiles of 
sieved PA powders were evaluated using a USP dissolution 
apparatus no. 1 (Erweka DT700, Germany). 
RESULTS AND DISCUSSION 
Morphology 
Following the crystallization of PA from ethanol in absence 
of any additives, PA crystals transformed from elongated 
habit (Figure 1a) to polyhedral-angular habit (Figure 1b).  
 
Figure 1. SEMs of untreated PA (a), Cry–PA (no additive) (b), 
Cry–PA in the presence of 0.1% (w/w) of Brij 58 (c), PVA (d), 
PEG 8000 (e), tensile strength of tablets comprised of 
untreated PA, Cry–PA (no additive), untreated 
Avicel:untreated PA physical mix, 2% (w/w) Avicel–Cry–PA 
and untreated Avicel:Cry–PA physical mix (f), Brij 58–Cry–
PA (g) and PEG 6000–Cry–PA (h). 
Additionally, the crystal size of untreated PA increased 
from a mean diameter (MD) of 148.3±10.8 µm to 
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197.8±8.4 µm. The crystal habit of PA crystallized in the 
presence of Brij 58 (Figure 1c) and PEG (Figure 1e) was 
subrounded-subangular whereas PA crystallized in the 
presence of PVA (Figure 3d) exhibited a polyhedral 
deformed habit. During crystallization, the additive could 
be adsorbed on the surfaces of the newly growing crystals, 
potentially competing for a site during the layer-by-layer 
crystal growth process, and thus could disrupt the 
intermolecular interactions between growth layers, leading 
to the formation of a crystal of a different habit. 
Solid-state 
Untreated and Cry–PAs produced comparable DSC scans 
as suggested by the presence of one endothermic transition 
at 170.9±1.1 ºC (melting onset = 169.2±0.3 ºC) (Figures not 
shown), corresponding to the melting of the stable form I 
(2). All the FT-IR bands representing the functional groups 
in the untreated PA were present in Cry–PAs with no shift 
(Figures not shown). This indicated that Cry–PAs did not 
undergo structural conversions compared to untreated 
monoclinic PA. This is considered advantageous because it 
allows the direct comparative evaluation of the PA 
products. 
Density and flowability 
True density of Cry–PA crystals was ≥ true density of 
untreated PA (1.27±0.02 – 1.60±0.01 g/cm3 versus 
1.26±0.02 g/cm
3
). Cry–PA (no additives) demonstrated a 
considerably higher tap density than untreated PA 
(0.90±0.03 versus 0.53±0.01 g/cm
3
). This could be due to 
the pronounced internal friction (i.e., additional void space) 
between untreated PA crystals due to their elongated habit 
(Figure 1a). All Cry–PA powders demonstrated improved 
flowability (CI: 10.1±2.4 – 43.1±2.7% versus 50.1±1.1%) 
compared to the untreated PA indicating their less cohesive 
behaviour. The better flowability of Cry–PA powders in 
comparison to untreated PA would be advantageous in 
achieving uniform tablet weight and hence acceptable drug 
content uniformity. 
Compression and compaction 
The Cry–PA (no additive) showed a slight improvement in 
compactibility in comparison to untreated PA (Figure 1f). 
Further improvement in tablet mechanical strength was 
observed when untreated PA was formulated with Avicel 
(Figure 1f). In comparison to both untreated PA and Cry–
PA without additive, a significant improved hardness was 
observed for PA crystallized in the presence of Brij 58 
(Figure 1g) and PEG 6000 (Figure 1h) at all compaction 
pressures; and to a lesser extent for PAs crystallized in the 
presence PEG 8000, PEG 1500, MC  and PVA (Figures not 
shown). Such improvement in compactibility could be due 
to the polyhedral-angular habit of the latter PA crystals, 
which could lead to increased interparticle contact points 
and thus increased degree of densification during 
compression. 
Dissolution  
Among PA formulations investigated, 1% Brij 58–Cry–PA 
demonstrated the fastest dissolution pattern as reflected by 
the highest dissolution efficiency (DE60min of 96.7±0.9%) 
and the shortest mean dissolution time (MDT of 2.0±1.0 
min), whereas untreated PA crystals demonstrated the 
shortest dissolution pattern as reflected by the lowest 
DE60min (90.1±0.2%) and the longest MDT (5.9±1.3% min) 
among PAs investigated (Figure 2). The relatively higher 
cohesive forces with untreated PA powder as indicated by 
CI (50.1 ± 1.1%) could potentially reduce the effective 
surface area for dissolution and thus may reduce 
bioavailability for untreated PA. Alternatively, the presence 
of hydrophilic additives could decrease the resistance to the 
effective diffusion of the solubilized PA in the case of Cry–
PAs. 
 
Figure 2. DE and MDT of untreated PA powder (a) and 
ethanol Cry–PA powders in the presence of different 
additives, i.e., Avicel (b), Brij 58 (0.1% (c), 0.5% (d), 1% w/w 
(e)), methylcellulose (MC, f) and polyethylene glycol (PEG 
6000, 0.1% w/w (g) and PEG 8000 0.1% (h), 0.5% (i) and 1% 
(j)). 
CONCLUSION 
Engineered paracetamols with improved micromeritic, 
mechanical and dissolution properties were prepared by 
antisolvent crystallization technique in the presence of 
various hydrophilic additives. The polyhedral crystallized 
form of paracetamol produced stronger tablets than 
elongated untreated crystals of paracetamol. paracetamols 
crystallized in the presence of Avicel, Brij 58 and PEG 
6000 were more advantageous and showed the best 
compactibility when compared to other paracetamols. 
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